Non-Hodgkin Lymphoma Program

Dana-Farber/Children's Hospital Cancer Center

If your child has been diagnosed with non-Hodgkin lymphoma, you probably have lots of questions about treatment. If your child has relapsed or hard-to-treat non-Hodgkin lymphoma, we provide direct access to the newest clinical trials and advanced therapies. Patient at the Jimmy Fund Clinic.

Here at Dana-Farber/Children’s Hospital Cancer Center (DF/CHCC), your child will receive care from many of the world’s most experienced pediatric oncologists at Dana-Farber Cancer Institute and internationally recognized pediatric subspecialists at Children’s Hospital Boston.

Our expertise

The non-Hodgkin Lymphoma Program is a special part of DF/CHCC.

All members of our team, which includes pediatric oncologists, radiation oncologists, surgeons, interventional and diagnostic radiologists and hematopathologists, have specific expertise in pediatric lymphomas.
We offer comprehensive diagnosis, treatment, consultation services for children and adolescents.
We provide access to multiple clinical trials investigating new treatment approaches, as well as advanced therapies like stem cell transplantation.
Our center offers a long-term care program specially designed for survivors of childhood cancer.

Did you know? Lymphoma

Lymphoma, which includes Hodgkin and non-Hodgkin disease, is the third most common cancer in children after leukemia and cancers of the brain and nervous system.

Did you know? Patient and family-centered care

We adhere to a patient and family-centered care model. Since 1999, our Pediatric Patient and Family Council has been instrumental in guiding our decision-making, from patient safety efforts to the design of our clinical facilities to quality improvement initiatives.